Edmund Harrigan
CIK: 0001177917
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 30, 2026INCY
INCYTE CORP
Award(A)Direct206 shares at avg. $121.35$25K - Jun 30, 2026INCY
INCYTE CORP
Award(A)Direct255 shares at avg. $113.36$29K - Jun 8, 2026INCY
INCYTE CORP
Award(A)Direct1.6K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
9.3K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
16K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct8.1K shares- - Mar 31, 2026INCY
INCYTE CORP
Award(A)Direct269 shares at avg. $94.12$25K - Dec 31, 2025INCY
INCYTE CORP
Award(A)Direct245 shares at avg. $98.77$24K - Sep 30, 2025INCY
INCYTE CORP
Award(A)Direct289 shares at avg. $84.81$25K - Jun 30, 2025INCY
INCYTE CORP
Award(A)Direct367 shares at avg. $68.10$25K - Jun 10, 2025INCY
INCYTE CORP
Award(A)Direct2.5K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
8.1K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct9.4K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
13.8K shares- - Mar 31, 2025INCY
INCYTE CORP
Award(A)Direct363 shares at avg. $60.55$22K - Dec 31, 2024INCY
INCYTE CORP
Award(A)Direct339 shares at avg. $69.07$23K - Sep 30, 2024INCY
INCYTE CORP
Award(A)Direct378 shares at avg. $66.10$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  INCY INCYTE CORP | Award(A) | 206 | $121.35 | $24,998 | Direct |
| Jun 30, 2026 | INCY INCYTE CORP | Award(A) | 255 | $113.36 | $28,907 | Direct |
| Jun 8, 2026 | INCY INCYTE CORP | Award(A) | 1,642 | - | $0 | Direct |
| May 29, 2026 |  ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 9,311 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 8,107 | - | $0 | Direct |
| Mar 31, 2026 | INCY INCYTE CORP | Award(A) | 269 | $94.12 | $25,318 | Direct |
| Dec 31, 2025 | INCY INCYTE CORP | Award(A) | 245 | $98.77 | $24,199 | Direct |
| Sep 30, 2025 | INCY INCYTE CORP | Award(A) | 289 | $84.81 | $24,510 | Direct |
| Jun 30, 2025 | INCY INCYTE CORP | Award(A) | 367 | $68.10 | $24,993 | Direct |
| Jun 10, 2025 | INCY INCYTE CORP | Award(A) | 2,518 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 8,107 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 9,387 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 13,793 | - | - | Direct |
| Mar 31, 2025 | INCY INCYTE CORP | Award(A) | 363 | $60.55 | $21,980 | Direct |
| Dec 31, 2024 | INCY INCYTE CORP | Award(A) | 339 | $69.07 | $23,415 | Direct |
| Sep 30, 2024 | INCY INCYTE CORP | Award(A) | 378 | $66.10 | $24,986 | Direct |
1-17 of 17 transactions
About HARRIGAN EDMUND
HARRIGAN EDMUND (SEC CIK 0001177917) files insider reports with the SEC as Director of INCYTE CORP (INCY) and Director of ACADIA PHARMACEUTICALS INC (ACAD).
Signal8 holds 13 ownership filings by HARRIGAN EDMUND, all Form 4s, filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 17 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HARRIGAN EDMUND's filings is in WILMINGTON, DE.
Recent filings by HARRIGAN EDMUND
- Sep 30, 2026: Grant or award of INCY shares (Form 4, code A).
- Jun 30, 2026: Grant or award of INCY shares (Form 4, code A).
- Jun 8, 2026: Grant or award of INCY shares (Form 4, code A).
- May 29, 2026: Grants or awards of ACAD derivative securities (2 lines, Form 4, code A).
- May 29, 2026: Option exercise of ACAD shares (Form 4, code M).
Other insiders filing for INCYTE CORP (INCY)
- CAGNONI PABLO J, President, Global Head of R&D
- Heeson Lee, EVP, Head of Incyte Intl
- BAKER BROS. ADVISORS LP, Director
- Clancy Paul J, Director
- Gardner David H, EVP, Chief Strategy Officer
- Basi Ramitpal K, EVP, Human Resources